Skip to main content
Premium Trial:

Request an Annual Quote

Natera, DiagCor Sign Deal to Bring Panorama NIPT to Hong Kong

NEW YORK (GenomeWeb News) – Natera today announced it has reached a deal with DiagCor to launch Natera's non-invasive prenatal screening test in Hong Kong.

DiagCor is based in Hong Kong and provides molecular diagnostic testing to doctors and healthcare professionals in the region.

The deal further expands the reach of Natera's test called Panorama into international markets and follows similar deals with the DASA Group and Hospital Israelita Albert Einstein to bring the test to Brazil, and with LifeLabs to make the Panorama available in Canada. In June Natera signed a distribution agreement with Unilabs covering Switzerland and Scandinavia.

Panorama uses a blood draw to detect trisomy 21, 18, and 13, as well as monosomy X, triploidy, and sex chromosome aneuploidies. It employs Natera's algorithm called Next Generation Aneuploidy Test Using SNPs to analyze the cell-free DNA from both the mother and the fetus.

Financial and other terms of today's deal were not disclosed.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.